Enliven Therapeutics Inc. monthly returns
Enliven Therapeutics Inc. has averaged 6.32% per month, positive in 44% of months. Month-by-month returns for Enliven Therapeutics Inc. (ELVN) below, through October 20, 2026 — the table lists the most recent months; the bar chart plots the last 5 years.
Enliven Therapeutics Inc. monthly returns#
| Month | Path | Total return |
|---|---|---|
| Oct 2026 | -10.0% | |
| Sep 2026 | -20.8% | |
| Aug 2026 | +5.6% | |
| Jul 2026 | +8.0% | |
| Jun 2026 | +28.3% | |
| May 2026 | -4.0% | |
| Apr 2026 | +5.2% | |
| Mar 2026 | +32.0% | |
| Feb 2026 | +12.2% | |
| Jan 2026 | +71.8% | |
| Dec 2025 | -28.7% | |
| Nov 2025 | -7.8% | |
| Oct 2025 | +14.4% | |
| Sep 2025 | +1.0% | |
| Aug 2025 | +7.8% | |
| Jul 2025 | -6.2% | |
| Jun 2025 | +12.9% | |
| May 2025 | -6.2% | |
| Apr 2025 | -3.8% | |
| Mar 2025 | -5.5% | |
| Feb 2025 | -4.7% | |
| Jan 2025 | -2.8% | |
| Dec 2024 | -7.7% | |
| Nov 2024 | -12.5% | |
| Oct 2024 | +9.0% | |
| Sep 2024 | +16.7% | |
| Aug 2024 | -17.1% | |
| Jul 2024 | +12.9% | |
| Jun 2024 | +3.5% | |
| May 2024 | +29.8% | |
| Apr 2024 | -1.1% | |
| Mar 2024 | +10.1% | |
| Feb 2024 | +1.7% | |
| Jan 2024 | +13.4% | |
| Dec 2023 | +22.9% | |
| Nov 2023 | -9.1% | |
| Oct 2023 | -9.3% | |
| Sep 2023 | -12.5% | |
| Aug 2023 | -17.5% | |
| Jul 2023 | -7.2% | |
| Jun 2023 | +11.5% | |
| May 2023 | -3.9% | |
| Apr 2023 | -13.1% | |
| Mar 2023 | +1.7% | |
| Feb 2023 | +366.2% | |
| Jan 2023 | +13.0% | |
| Dec 2022 | -4.0% | |
| Nov 2022 | -4.1% | |
| Oct 2022 | +94.7% | |
| Sep 2022 | +93.2% | |
| Aug 2022 | +0.9% | |
| Jul 2022 | -4.1% | |
| Jun 2022 | +0.8% | |
| May 2022 | -9.7% | |
| Apr 2022 | -28.7% | |
| Mar 2022 | +23.7% | |
| Feb 2022 | +9.4% | |
| Jan 2022 | -38.2% | |
| Dec 2021 | -33.4% | |
| Nov 2021 | -6.1% | |
| Oct 2021 | -11.8% | |
| Sep 2021 | -14.8% | |
| Aug 2021 | -11.1% | |
| Jul 2021 | -31.8% | |
| Jun 2021 | +8.7% | |
| May 2021 | -1.8% | |
| Apr 2021 | -12.3% | |
| Mar 2021 | -33.0% | |
| Feb 2021 | -3.3% | |
| Jan 2021 | -41.0% | |
| Dec 2020 | -13.6% | |
| Nov 2020 | +61.4% | |
| Oct 2020 | -22.3% | |
| Sep 2020 | -12.5% | |
| Aug 2020 | +15.1% | |
| Jul 2020 | -26.9% | |
| Jun 2020 | -17.5% | |
| May 2020 | +91.4% | |
| Apr 2020 | +9.2% |
Monthly total return (since Nov 2021)#
Enliven Therapeutics Inc. returns by calendar month#
Every month of every year since 2021, one tick per year on a shared scale; the dark bar is the month's average. Total returns, dividends reinvested.
October 2026 so far: -10.01% — 5th of 6 Octobers since 2021 at the last close; the average October returned +19.4%.
| Month | −370%0+370% | Average | Median | Up | Best | Worst |
|---|---|---|---|---|---|---|
| Jan | +2.7% | +5.1% | 50% | +71.8% 2026 | -41.0% 2021 | |
| Feb | +63.6% | +5.5% | 67% | +366.2% 2023 | -4.7% 2025 | |
| Mar | +4.8% | +5.9% | 67% | +32.0% 2026 | -33.0% 2021 | |
| Apr | -9.0% | -8.0% | 17% | +5.2% 2026 | -28.7% 2022 | |
| May | +0.7% | -4.0% | 17% | +29.8% 2024 | -9.7% 2022 | |
| Jun | +11.0% | +10.1% | 100% | +28.3% 2026 | +0.8% 2022 | |
| Jul | -4.7% | -5.2% | 33% | +12.9% 2024 | -31.8% 2021 | |
| Aug | -5.2% | -5.1% | 50% | +7.8% 2025 | -17.5% 2023 | |
| Sep | +10.5% | -5.8% | 50% | +93.2% 2022 | -20.8% 2026 | |
| Oct | +19.4% | +9.0% | 60% | +94.7% 2022 | -11.8% 2021 | |
| Nov | -7.9% | -7.8% | 0% | -4.1% 2022 | -12.5% 2024 | |
| Dec | -10.2% | -7.7% | 20% | +22.9% 2023 | -33.4% 2021 |
Methodology#
Monthly returns are total returns (dividends reinvested), computed from ELVN's split- and dividend-adjusted month-end closes. The table shows the most recent 120 months and the bar chart the most recent 60. See the year-by-year returns for the annual view. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Enliven Therapeutics Inc.'s average monthly return?
- Enliven Therapeutics Inc. (ELVN) has averaged about 6.32% per month, positive in roughly 44% of months. The best month was Feb 2023 (+366.2%) and the worst was Jan 2021 (-41.0%).